Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
PaperCitations, authors & open-access status
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 336 citations, 2023 year and green oa status.
336
Citations
2023
Year
green
OA Status